These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25839418)

  • 21. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
    Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
    Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins.
    Palatnik de Sousa CB; Santos WR; Casas CP; Paraguai de Souza E; Tinoco LW; da Silva BP; Palatnik M; Parente JP
    Vaccine; 2004 Jun; 22(19):2470-9. PubMed ID: 15193411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in saponin-based adjuvants.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
    Deng K; Adams MM; Gin DY
    J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of an Immunoadjuvant Saponin Fraction from Quillaja brasiliensis Leaves by Reversed-Phase Silica Gel Chromatography.
    Yendo AC; de Costa F; Kauffmann C; Fleck JD; Gosmann G; Fett-Neto AG
    Methods Mol Biol; 2017; 1494():87-93. PubMed ID: 27718187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines.
    Kirk DD; Rempel R; Pinkhasov J; Walmsley AM
    Expert Opin Biol Ther; 2004 Jun; 4(6):947-58. PubMed ID: 15174976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrospray ionization ion-trap multiple-stage mass spectrometry of Quillaja saponins.
    Bankefors J; Broberg S; Nord LI; Kenne L
    J Mass Spectrom; 2011 Jul; 46(7):658-65. PubMed ID: 21706675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
    Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
    Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
    de Groot C; Müller-Goymann CC
    Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alum-type adjuvant effect of non-haemolytic saponins purified from Ilex and Passiflora spp.
    Silveira F; Rossi S; Fernández C; Gosmann G; Schenkel E; Ferreira F
    Phytother Res; 2011 Dec; 25(12):1783-8. PubMed ID: 21480409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
    Behboudi S; Morein B; Villacres-Eriksson M
    Cytokine; 1997 Sep; 9(9):682-7. PubMed ID: 9325017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    Adams MM; Damani P; Perl NR; Won A; Hong F; Livingston PO; Ragupathi G; Gin DY
    J Am Chem Soc; 2010 Feb; 132(6):1939-45. PubMed ID: 20088518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
    Brunner L; Barnier-Quer C; Collin N
    Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
    Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF
    J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basidiolipids from Agaricus are novel immune adjuvants.
    Jennemann R; Bauer BL; Bertalanffy H; Selmer T; Wiegandt H
    Immunobiology; 1999 Jun; 200(2):277-89. PubMed ID: 10416134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QS-21 and QS-7: purified saponin adjuvants.
    Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
    Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography/mass spectrometry for product authentication.
    Kite GC; Howes MJ; Simmonds MS
    Rapid Commun Mass Spectrom; 2004; 18(23):2859-70. PubMed ID: 15517552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of new immunoadjuvant saponin named QB-90, and analysis of its organ-specific distribution in Quillaja brasiliensis by HPLC.
    Fleck JD; de Costa F; Yendo AC; Segalin J; Dalla Costa TC; Fett-Neto AG; Gosmann G
    Nat Prod Res; 2013; 27(10):907-10. PubMed ID: 22404569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.